These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12569958)

  • 1. Therapeutic use of botulinum toxins: background and history.
    Setler PE
    Clin J Pain; 2002; 18(6 Suppl):S119-24. PubMed ID: 12569958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.
    Lew MF
    Clin J Pain; 2002; 18(6 Suppl):S142-6. PubMed ID: 12569961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding use of botulinum toxin.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins.
    Davletov B; Bajohrs M; Binz T
    Trends Neurosci; 2005 Aug; 28(8):446-52. PubMed ID: 15979165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxins in neurological disease.
    Comella CL; Pullman SL
    Muscle Nerve; 2004 May; 29(5):628-44. PubMed ID: 15116366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of botulinum neurotoxins to different peripheral neurons.
    Rossetto O
    Toxicon; 2018 Jun; 147():27-31. PubMed ID: 29042309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanisms for the effects of botulinum toxin on pain.
    Arezzo JC
    Clin J Pain; 2002; 18(6 Suppl):S125-32. PubMed ID: 12569959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A focused review on the use of botulinum toxins for neuropathic pain.
    Argoff CE
    Clin J Pain; 2002; 18(6 Suppl):S177-81. PubMed ID: 12569966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to the Toxins Special Issue on Botulinum Neurotoxins in the Nervous System: Future Challenges for Novel Indications.
    Luvisetto S
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32957443
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use.
    Hambleton P
    J Neurol; 1992 Jan; 239(1):16-20. PubMed ID: 1311751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum toxin in clinical neurology].
    Wissel J; Kempf F
    Fortschr Neurol Psychiatr; 2012 Mar; 80(3):167-78; quiz 179. PubMed ID: 22407413
    [No Abstract]   [Full Text] [Related]  

  • 13. [Botulinum toxin: structure, mode of action and therapeutic use].
    Tatarkiewicz J
    Postepy Hig Med Dosw; 1994; 48(5):505-20. PubMed ID: 7638099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy with botulinum toxin: harnessing nature's most potent neurotoxin.
    Bell MS; Vermeulen LC; Sperling KB
    Pharmacotherapy; 2000 Sep; 20(9):1079-91. PubMed ID: 10999501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum neurotoxin detection and differentiation by mass spectrometry.
    Barr JR; Moura H; Boyer AE; Woolfitt AR; Kalb SR; Pavlopoulos A; McWilliams LG; Schmidt JG; Martinez RA; Ashley DL
    Emerg Infect Dis; 2005 Oct; 11(10):1578-83. PubMed ID: 16318699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxins: mechanisms of action, antinociception and clinical applications.
    Wheeler A; Smith HS
    Toxicology; 2013 Apr; 306():124-46. PubMed ID: 23435179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of botulinum neurotoxin serotype A.
    Wenzel RG
    Am J Health Syst Pharm; 2004 Nov; 61(22 Suppl 6):S5-10. PubMed ID: 15598004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects.
    Pickett A
    BioDrugs; 2010 Jun; 24(3):173-82. PubMed ID: 20462283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlabeled uses of botulinum toxins: a review, part 1.
    Cheng CM; Chen JS; Patel RP
    Am J Health Syst Pharm; 2006 Jan; 63(2):145-52. PubMed ID: 16390928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery from botulinum neurotoxin poisoning in vivo.
    Keller JE
    Neuroscience; 2006 May; 139(2):629-37. PubMed ID: 16490322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.